Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
2011

Comparing Treatment Patterns of Duloxetine and Venlafaxine for Depression

Sample size: 18155 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ye Wenyu, Zhao Yang, Robinson Rebecca L, Swindle Ralph W

Primary Institution: Lilly USA, LLC

Hypothesis

Are duloxetine and venlafaxine XR interchangeable in their patterns of use for patients with major depressive disorder?

Conclusion

Patients treated with duloxetine tend to have a more complex and costly clinical presentation compared to those treated with venlafaxine XR.

Supporting Evidence

  • Patients treated with duloxetine were more likely to have a history of comorbid psychiatric and nonpsychiatric conditions.
  • Duloxetine initiators had higher previous health care costs compared to venlafaxine XR patients.
  • Logistic regression analysis showed that 61% of patients' treatment choices could be predicted from prior characteristics.

Takeaway

This study looked at how two medications for depression are used. It found that one medication is often given to patients with more complicated health issues.

Methodology

Retrospective analysis of an administrative insurance claims database studying patients with major depressive disorder treated with duloxetine or venlafaxine XR.

Potential Biases

Potential biases may exist due to unmeasured factors and the exclusion of patients not meeting inclusion criteria.

Limitations

The study is subject to selection biases and unmeasured confounding factors due to its retrospective nature.

Participant Demographics

Patients were aged 18 to 64, with a higher proportion of females in the duloxetine group.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1471-244X-11-19

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication